Northeast Financial Consultants’s AbbVie ABBV Stock Holding History

Northeast Financial Consultants’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.13M	Hold	16,867	–	–	0.13%	86
2025 Q1	$3.53M	Hold	16,867	–	–	0.16%	76
2024 Q4	$3M	Hold	16,867	–	–	0.13%	87
2024 Q3	$3.33M	Buy	16,867 +37	+0.2%	+$7.31K	0.15%	81
2024 Q2	$2.89M	Sell	16,830 -700	-4%	-$120K	0.13%	86
2024 Q1	$3.19M	Buy	17,530 +1,183	+7%	+$215K	0.16%	86
2023 Q4	$2.53M	Hold	16,347	–	–	0.14%	93
2023 Q3	$2.44M	Sell	16,347 -2,156	-12%	-$321K	0.15%	95
2023 Q2	$2.49M	Buy	18,503 +22	+0.1%	+$2.96K	0.15%	91
2023 Q1	$2.95M	Sell	18,481 -1,745	-9%	-$278K	0.19%	81
2022 Q4	$3.27M	Buy	20,226 +1,895	+10%	+$306K	0.22%	72
2022 Q3	$2.46M	Buy	18,331 +830	+5%	+$111K	0.18%	80
2022 Q2	$2.68M	Sell	17,501 -572	-3%	-$87.6K	0.19%	80
2022 Q1	$2.93M	Buy	18,073 +302	+2%	+$49K	0.17%	84
2021 Q4	$2.41M	Sell	17,771 -1,326	-7%	-$180K	0.15%	79
2021 Q3	$2.06M	Buy	19,097 +227	+1%	+$24.5K	0.14%	93
2021 Q2	$2.13M	Sell	18,870 -62	-0.3%	-$6.99K	0.14%	92
2021 Q1	$2.05M	Buy	18,932 +209	+1%	+$22.6K	0.16%	86
2020 Q4	$2.01M	Hold	18,723	–	–	0.17%	82
2020 Q3	$1.64M	Buy	18,723 +481	+3%	+$42.1K	0.15%	87
2020 Q2	$1.79M	Buy	18,242 +6,744	+59%	+$662K	0.17%	77
2020 Q1	$876K	Buy	11,498 +10	+0.1%	+$762	0.1%	129
2019 Q4	$1.02M	Buy	11,488 +576	+5%	+$51K	0.09%	134
2019 Q3	$826K	Buy	10,912 +136	+1%	+$10.3K	0.08%	144
2019 Q2	$784K	Buy	10,776 +107	+1%	+$7.79K	0.08%	148
2019 Q1	$860K	Sell	10,669 -58	-0.5%	-$4.68K	0.1%	130
2018 Q4	$989K	Buy	10,727 +6,216	+138%	+$573K	0.14%	96
2018 Q3	$426K	Buy	4,511 +1,591	+54%	+$150K	0.12%	94
2018 Q2	$270K	Hold	2,920	–	–	0.08%	115
2018 Q1	$276K	Sell	2,920 -324	-10%	-$30.6K	0.09%	121
2017 Q4	$313K	Buy	3,244 +324	+11%	+$31.3K	0.1%	112
2017 Q3	$259K	Hold	2,920	–	–	0.09%	127
2017 Q2	$212K	Sell	2,920 -200	-6%	-$14.5K	0.08%	134
2017 Q1	$203K	Buy	+3,120	New	+$203K	0.08%	142